Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation
- PMID: 10864968
- PMCID: PMC6772265
- DOI: 10.1523/JNEUROSCI.20-13-05115.2000
Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation
Abstract
Huntington's disease (HD) is an autosomal dominant progressive and fatal neurodegenerative brain disorder caused by an expanded CAG/polyglutamine repeat in the coding region of the gene. Presymptomatic Huntington's disease patients often exhibit cognitive deficits before the onset of classical symptoms. To investigate the possibility that changes in synaptic plasticity might underlie cognitive impairment in HD, we examined hippocampal synaptic plasticity and spatial cognition in a transgenic mouse (R6/2 line) expressing exon 1 of the human Huntington's disease gene containing an expanded CAG repeat. This mouse exhibits a progressive and fatal neurological phenotype that resembles Huntington's disease. We report that R6/2 mice show marked alterations in synaptic plasticity at both CA1 and dentate granule cell synapses, and impaired spatial cognitive performance in the Morris water maze. The changes in hippocampal plasticity were age dependent, appearing at CA1 synapses several weeks before they were observed in the dentate gyrus. Deficits in synaptic plasticity at CA1 synapses occurred before an overt phenotype. This suggests that altered synaptic plasticity contributes to the pre-symptomatic changes in cognition reported in human carriers of the Huntington' disease gene. The temporal and regional changes in synaptic plasticity within the hippocampus mirror the appearance of neuronal intranuclear inclusions, suggesting a relationship between polyglutamine aggregation and dysfunction.
Figures
![Fig. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6772265/bin/ns1204253001.gif)
![Fig. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6772265/bin/ns1204253002.gif)
![Fig. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6772265/bin/ns1204253003.gif)
![Fig. 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6772265/bin/ns1204253004.gif)
![Fig. 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6772265/bin/ns1204253005.gif)
![Fig. 6.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6772265/bin/ns1204253006.gif)
Similar articles
-
Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease.Neuroscience. 2013 Oct 22;251:66-74. doi: 10.1016/j.neuroscience.2012.05.043. Epub 2012 May 24. Neuroscience. 2013. PMID: 22633949 Review.
-
Progressive imbalance in the interaction between spatial and procedural memory systems in the R6/2 mouse model of Huntington's disease.Neurobiol Learn Mem. 2009 Oct;92(3):417-28. doi: 10.1016/j.nlm.2009.06.002. Epub 2009 Jun 12. Neurobiol Learn Mem. 2009. PMID: 19524696
-
Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice.Neurobiol Dis. 2008 Mar;29(3):490-504. doi: 10.1016/j.nbd.2007.11.006. Epub 2007 Nov 24. Neurobiol Dis. 2008. PMID: 18165017
-
Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease.Hum Mol Genet. 2006 May 15;15(10):1690-703. doi: 10.1093/hmg/ddl092. Epub 2006 Apr 6. Hum Mol Genet. 2006. PMID: 16600988
-
Transgenic models of Huntington's disease.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):963-9. doi: 10.1098/rstb.1999.0447. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434294 Free PMC article. Review.
Cited by
-
Exploring the Role of Neuroplasticity in Development, Aging, and Neurodegeneration.Brain Sci. 2023 Nov 21;13(12):1610. doi: 10.3390/brainsci13121610. Brain Sci. 2023. PMID: 38137058 Free PMC article. Review.
-
Exploration of the Shared Molecular Mechanisms between COVID-19 and Neurodegenerative Diseases through Bioinformatic Analysis.Int J Mol Sci. 2023 Mar 2;24(5):4839. doi: 10.3390/ijms24054839. Int J Mol Sci. 2023. PMID: 36902271 Free PMC article.
-
Huntingtin-associated protein 1-associated intracellular trafficking in neurodegenerative diseases.Front Aging Neurosci. 2023 Feb 7;15:1100395. doi: 10.3389/fnagi.2023.1100395. eCollection 2023. Front Aging Neurosci. 2023. PMID: 36824265 Free PMC article. Review.
-
Neuroinflammation in Huntington's disease: From animal models to clinical therapeutics.Front Immunol. 2022 Dec 22;13:1088124. doi: 10.3389/fimmu.2022.1088124. eCollection 2022. Front Immunol. 2022. PMID: 36618375 Free PMC article. Review.
-
Differential expression and roles of Huntingtin and Huntingtin-associated protein 1 in the mouse and primate brains.Cell Mol Life Sci. 2022 Oct 17;79(11):554. doi: 10.1007/s00018-022-04577-8. Cell Mol Life Sci. 2022. PMID: 36251080
References
-
- Becher MW, Kotzuk JA, Sharp AH, Davies SW, Bates GP, Price DL, Ross CA. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and Pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol Dis. 1998;4:387–397. - PubMed
-
- Biessels G-J, Kamal A, Urban IJA, Spruijt BM, Erkelens DW, Gispen WH. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res. 1998;800:125–135. - PubMed
-
- Bliss TVP, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993;361:31–39. - PubMed
-
- Blitzer RD, Wong T, Nouranifar R, Iyengar R, Landau EM. Postsynaptic cAMP pathway gates early LTP in hippocampal CA1 region. Neuron. 1995;15:1403–1414. - PubMed
-
- Bortolotto ZA, Bashir ZI, Davies CH, Collingridge GL. A molecular switch activated by metabotropic glutamate receptors regulates induction of long-term potentiation. Nature. 1994;368:740–743. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous